>
Tell General Mills To Reject GMO Wheat!
Climate Scientists declare the climate "emergency" is over
Trump's Cabinet is Officially Complete - Meet the Team Ready to Make America Great Again
Former Polish Minister: At Least Half of US Aid Was Laundered by Ukrainians...
Forget Houston. This Space Balloon Will Launch You to the Edge of the Cosmos From a Floating...
SpaceX and NASA show off how Starship will help astronauts land on the moon (images)
How aged cells in one organ can cause a cascade of organ failure
World's most advanced hypergravity facility is now open for business
New Low-Carbon Concrete Outperforms Today's Highway Material While Cutting Costs in Minnesota
Spinning fusion fuel for efficiency and Burn Tritium Ten Times More Efficiently
Rocket plane makes first civil supersonic flight since Concorde
Muscle-powered mechanism desalinates up to 8 liters of seawater per hour
Student-built rocket breaks space altitude record as it hits hypersonic speeds
Researchers discover revolutionary material that could shatter limits of traditional solar panels
MIT Technology Review reports that the first use of CRISPR in humans, to edit immune cells, has been proposed by scientists at the University of Pennsylvania. The National Institutes of Health's Recombinant DNA Advisory Committee will meet next week to review the the use of the technology.
The NIH writes in a blog post that the technique would be used to edit two genes in human T cells, which would target myeloma, melanoma, and sarcoma tumor cells.
This comes after an earlier proposal from Editas, a biotech company that plans to use CRISPR to treat eye disorders in 2017.